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Abstract
Peripheral CD8
+ T cells are defective in both IL-15 and IL-15Ra knock-out (KO) mice; however, whether IL-15/IL-15Ra
deficiency has a similar effect on CD8 single-positive (SP) thymocytes remains unclear. In this study, we investigated
whether the absence of IL-15 transpresentation in IL-15Ra KO mice results in a defect in thymic CD8 single positive (SP)
TCR
hi thymocytes. Comparison of CD8SP TCR
hi thymocytes from IL-15Ra KO mice with their wild type (WT) counterparts by
flow cytometry showed a significant reduction in the percentage of CD69
2 CD8SP TCR
hi thymocytes, which represent
thymic premigrants. In addition, analysis of in vivo 5-bromo-2-deoxyuridine (BrdU) incorporation demonstrated that
premigrant expansion of CD8SP TCR
hi thymocytes was reduced in IL-15Ra KO mice. The presence of IL-15 transpresentation-
dependent expansion in CD8SP TCR
hi thymocytes was assessed by culturing total thymocytes in IL-15Ra-Fc fusion protein-
pre-bound plates that were pre-incubated with IL-15 to mimic IL-15 transpresentation in vitro. The results demonstrated
that CD8SP thymocytes selectively outgrew other thymic subsets. The contribution of the newly divided CD8SP thymocytes
to the peripheral CD8
+ T cell pool was examined using double labeling with intrathymically injected FITC and intravenously
injected BrdU. A marked decrease in FITC
+ BrdU
+ CD8
+ T cells was observed in the IL-15Ra KO lymph nodes. Through these
experiments, we identified an IL-15 transpresentation-dependent proliferation process selective for the mature CD8SP
premigrant subpopulation. Importantly, this process may contribute to the maintenance of the normal peripheral CD8
+ T
cell pool.
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Introduction
The intrathymic development of T cells is a differentiation
process in which bone marrow derived progenitors progress
through an immature CD4
2CD8
2 double-negative (DN) TCR
neg
stage, a CD4
+CD8
+ double-positive (DP) TCR
lo stage, and a
mature CD4
+ single-positive (SP) TCR
hi or CD8SP TCR
hi T cell
stage [1]. In addition, a transitional CD8SP TCR
neg/lo stage exists
prior to the DP stage [2]. Accompanying this differentiation
process is a stage-wise cell expansion process. The earliest cell
expansion takes place in DN thymocytes prior to TCR gene
rearrangement [3]. Cell expansion also commences upon b-
selection and continues through the proliferation-dependent DN
to DP transition [4,5]. Intriguingly, mature SP TCR
hi thymocytes
that survive positive and negative selection undergo cell expansion
several hours prior to their egress to the periphery. This
premigration expansion takes place after the thymocyte selection
processes and is therefore referred to as post-selection proliferation
[1,6,7]. In vivo BrdU incorporation studies have demonstrated that
post-selection proliferation accounts for approximately 4610
5 SP
TCR
hi cells in adult mice [1,8]; the majority of these cells are
CD8SP thymocytes [1,9]. Half of these cycling cells (2610
5)
terminate their DNA synthesis upon egress to the periphery and
account for 10% of the 2610
6 daily T cell output [1,10,11],
demonstrating the significant contribution of post-selection
proliferation to the peripheral CD8
+ T cell pool.
IL-15 is an inflammatory cytokine identified on the basis of its
ability to support T cell growth [12]. The receptor for IL-15
consists of a, b, and cc chains, with the b-chain and cc chain being
shared by IL-2R and the receptors for IL-2, IL-4, IL-7, IL-9, and
IL-21, respectively [13,14]. It has recently been established that
IL-15 must be autonomously transpresented by its proprietary IL-
15Ra chain to the IL-15Rbcc-bearing responding cells to exert its
functional activities; this phenomenon is referred to as IL-15
transpresentation [15–18]. Previous studies showed that mice
ablated of IL-15Ra bear similar absolute numbers of splenic white
blood cells but 30% fewer lymph node (LN) cells compared with
WT mice [19,20]. Further analysis indicated that the percentage
of CD8
+ T cells was reduced by 50% in spleens, LNs, and blood in
IL-15Ra KO mice. There are approximately 7610
6 CD8
+ T cells
in IL-15Ra KO spleen versus 14.7610
6 in WT mice counterparts.
The average number of CD8
+ T cells per LN in IL-15Ra KO and
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33152WT mice was 1.8610
5 and 4.8610
5, respectively [20]. Subsequent
bone marrow chimerism studies involving reciprocal adoptive
transfer of T cell-depleted bone marrow cells from wild type (WT)
or IL-15Ra KO mice to irradiated recipients demonstrated an
absolute requirement for IL-15 transpresentation for the mainte-
nance of peripheral CD8
+ T cells [21]. Despite these findings,
whether IL-15 transpresentation is essential for thymic CD8
+ T cell
development and thus regulates the peripheral CD8
+ T cell pool
remains largely unknown. In previous studies, IL-15 was shown to
stimulate the proliferation of CD8SP thymocytes that were isolated
from mice deficient in suppressor of cytokine signaling 1 (SOCS-1),
a negative regulator of cytokine signaling [22–27]. However, the in
vitro proliferation of WT CD8
+ SP thymocytes has been reported to
require IL-15 and another cc-dependent cytokine IL-21 [22,26,28].
The presence of IL-21 significantly enhances IL-15-mediated
STAT5 phosphorylation, which may contribute to its synergistic
effect on CD8
+ T cell expansion [28].
To determine whether IL-15 supports CD8SP thymocyte
expansion through transpresentation, which also contributes to
the peripheral T cell pool, we directly compared the number of
cells undergoing blastogenesis and the incorporation of 5-bromo-
2-deoxyuridine (BrdU) by mature SP thymocytes in vivo in WT and
IL-15Ra KO mice using flow cytometry. The requirement for IL-
15 transpresentation for premigration expansion was also
examined in in vitro cultures supplemented with pre-bound IL-
15/IL-15Ra-Fc fusion protein. The contribution of premigration
expansion to the peripheral T cell pool was subsequently
examined by comparing the frequency of BrdU
+ recent thymic
emigrants (RTEs) identified by intrathymic fluorescein isothiocy-
anate (FITC) injection in WT and IL-15Ra KO mice.
Materials and Methods
Ethics statement
Animal ethics approval for the immunization studies in mice
was obtained from the Institutional Animal Care and Use
Committee (IACUC) at the Chang Gung University. All animal
studies were performed in compliance with the guidelines of the
Institutional Animal Care and Use Committee (IACUC) under
approval from the IACUC at the Chang Gung University (Permit
Number CGU 10-042).
Mice and cell lines
IL-15Ra KO mice were previously generated as described [20]
and backcrossed to C57BL/6 (B6) mice for 16 to 20 generations.
Mice used in this study were bred under specific pathogen-free
(SPF) conditions at the animal facility of Chang-Gung University.
The experimental protocols conducted were approved by the
Animal Ethics Committee, Chang Gung University. All mice were
used at 6–8 weeks of age. The mouse lymphoma cell line EG7-IL-
21H, which constitutively expresses IL-21 [29], was a gift provided
by Dr. C.R. Shen of Chang Gung University, Taiwan.
Medium and cytokines
RPMI-1640 medium (Invitrogen Life Technologies, Carlsbad,
CA, USA) was supplemented with 10% heat-inactivated fetal calf
serum (Biological Industries, Israel), 2 mM L-glutamine, 20 mM
HEPES-NaOH (pH 7.2, Merck, NJ, USA), 2000 U/L penicillin-
streptomycin (Invitrogen Life Technologies), and 50 mM b–mercap-
toethanol (Merck). Recombinant mouse IL-15 was purchased from
PeproTech, Inc. (PeproTech, Rocky Hill, NJ, USA). IL-21 was
obtained from the supernatant collected 4 hours after culturing the
IL-21-expressing cell line EG7-IL-21H [29]. The concentration of
IL-21 was 6 ng/ml, as determined by a DuoSet ELISA kit (data not
shown) (R&D Systems, Inc., Minneapolis, MN, USA).
Flow cytometry
All cells were stained and analyzed using either a FACSCalibur
or FACSCanto II flow cytometer (BD Biosciences, San Jose, CA,
USA). For FACSCalibur analysis, cells were stained with anti-
CD8a-FITC (clone 53-6.7), anti-CD4-biotin (clone GK1.5), and
anti-TCRb-PE (clone H57) in Mg
2+- and Ca
2+-free Dulbecco’s
phosphate buffer saline (PBS) containing 2% heat-inactivated FCS
and 0.1% NaN3 (Life Technologies, Rockville, MD). The cells
stained with biotin-conjugated Abs were washed and subsequently
stained by allophycocyanin (APC)-conjugated streptavidin. The
data acquired were then analyzed using Flow Jo software (Tree
Star, Ashland, OR). For FACSCanto II analysis, cells were stained
with anti-CD4-PE, anti-CD8-eFluorH 450, anti-TCRb-FITC,
anti-CD69-PE-Cy7 (clone H1.2F3) and anti-BrdU-APC. The cells
stained with biotin-conjugated Abs were washed and stained with
APC-conjugated streptavidin. All antibodies were purchased from
eBioscience (San Diego, CA, USA).
Isolation of SP thymocytes
Thymocytes were prepared as single-cell suspensions, and CD4
+
thymocytes, including DP and CD4SP cells, were positively
selected using CD4 (L3T4) MicroBeads (130-049-201, Miltenyi
Biotec, Auburn, CA, USA) following the manufacturer’s instruc-
tions. The flow-through was collected, and CD8SP thymocytes
were positively selected using a CD8a
+ T Cell Isolation Kit (130-
090-859, Miltenyi Biotec). Isolated CD8SP thymocytes were
routinely $90% pure.
BrdU assay
To examine differences in cell division, WT and IL-15Ra KO
mice were injected intraperitoneally (i.p.) with 100 mLo f1 0mg/mL
of BrdU (BD Biosciences) and sacrificed 1 hr later. Total thymocytes
were collected and prepared as a single-cell suspension. For some
experiments, CD8SP thymocytes were separated from CD4SP and
DP thymocytes as described above. Cells were subsequently
subjected to surface staining and permeabilized for intracellular
staining of BrdU using a BrdU labeling kit (BD Biosciences).
In vitro T cell proliferation assay
Total thymocytes were prepared as a single-cell suspension and
labeled with 5 mM CFSE (VybrantH CFDA SE Cell Tracer Kit,
V-12883, Invitrogen Life Technologies, Molecular Probes). Cells
(1610
5/mL) were then cultured in 96-well U-bottom plates
containing 100 mL of medium supplemented with either 20 ng/ml
murine IL-15 (PeproTech) or 6 ng/mL IL-21 or with both IL-15
and IL-21. For IL-15 transpresentation, wells were pre-coated with
3 mg/mL recombinant murine (rm) IL-15Ra-Fc fusion protein
(R&D Systems) for 1 hr at 37uC. Plates were then blocked with
PBS containing 5% serum for an equivalent length of time. IL-15
was added, and the plates were incubated for 1 hr at 37uC. Plates
were then washed three times with PBS containing 5% serum.
Next, total thymocytes were seeded in medium containing IL-21.
Three days after seeding, the cultures were supplemented with an
additional 100 mL of medium containing identical amounts of the
same cytokine. Two days later, the cells were harvested and
subjected to immunostaining and flow cytometric analysis.
Detection of cycling RTEs by intrathymic FITC injection
Mice were injected twice with BrdU i.p.at a 2-hr interval to
improve the labelling efficiency [1,30]. Four hours after the second
BrdU injection, mice were injected intrathymically with FITC as
previously described [31]. Briefly, mice were anesthetized via an
i.p. injection of 350 mL containing 0.75 mg ketamine hydrochlo-
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opened, and each thymic lobe was injected with 10 mL of 350 mg/
mL FITC in 16PBS. The chest was closed with a surgical staple,
and the mice were warmed until fully recovered from anaesthesia.
Mice were sacrificed 16 hrs after the BrdU injection by CO2
asphyxiation, and thymuses and lymph nodes (LNs) were
removed. LN cells were subsequently stained for the expression
of CD4 and CD8 and subjected to a BrdU assay. Flow cytometric
analysis demonstrated that 60% of thymic cells were routinely
labeled with FITC in both WT and IL-15Ra KO mice.
Statistical analysis
Data are expressed as means 6 SD and were compared among
groups by single-classification ANOVA. A value of p,0.05 was
considered to be statistically significant.
Results
Thymocytes develop normally in the absence of IL-15
transpresentation
To determine whether there is a defect in intrathymic T cell
development in the absence of IL-15 transpresentation, total
thymocytes were isolated from WT and IL-15Ra KO mice and
immunostained for CD4, CD8, and TCR to compare the
frequencies of the DN, DP, and SP subpopulations in these mice.
As shown in Fig. 1A and 1B, the compositions of the intrathymic
DN, DP, CD4SP and CD8SP subpopulations were comparable
betweenthetwomousestrains.Furthermore,themajorityofCD4SP
thymocytes ($95%) were TCR
hi mature cells (Fig. 1C, right two
panels). In contrast, the CD8SP subpopulation was composed of
approximately 80% mature TCR
hi cells and 20% immature cells
with low or negative TCR expression (Fig. 1C, left two panels) [2].
Further comparison of CD8SP cells in these two groups of mice
showed that the total thymocytes population contained similar
percentages of immature CD8SP TCR
neg/lo and mature CD8SP
TCR
hi cells in both mouse strains (Fig. 1D). Together with our
previous finding that the frequency of cells in the four DN stages
defined by the expression of CD44 and CD25 did not differ between
WT and IL-15Ra KO mice [20], these results demonstrate that T
cells develop in an IL-15 transpresentation-independent manner
from DN progenitors to mature SP thymocytes.
IL-15Ra KO thymus was selectively impaired in CD8SP
premigrants
CD69 was known for its upregulation on newly activated
peripheral T cells. However, DP thymocytes that were undergoing
or have just undergone positive selection were also found to
express CD69 [32,33]. It was reported that CD69 mediated the
Figure 1. Characterization of thymocyte subpopulations in WT and IL-15Ra KO mice. Total thymocytes were isolated from WT and IL-15Ra
KO mice (n=5 per group) and subjected to flow cytometric analysis of the expression of CD4, CD8, and TCRb. (A) Thymic subsets of WT and IL-15Ra
KO mice were shown for their expression of CD4 and CD8. (B) Percentages of DN, DP, CD4SP, and CD8SP thymocytes among total thymocytes of IL-
15Ra KO (#) mice and wild-type littermates (N) were compared. The horizontal line represents the mean. (C) CD4SP and CD8SP thymocytes were
further gated to compare their TCR expression. CD8SP thymocytes consisted of TCR
neg/lo and TCR
hi cells, whereas the majority of CD4SP cells
expressed high levels of TCR. (D) The percentage of CD8SP TCR
hi cells (left panel) and CD8SP TCR
neg/lo cells (right panel) among total thymocytes was
compared between WT and IL-15Ra KO mice. Data were analyzed by single-classification ANOVA. n.s., not significant.
doi:10.1371/journal.pone.0033152.g001
Figure 2. Examination of CD69-negative SP thymocytes in WT and IL-15Ra KO mice. Thymocytes of WT and IL-15Ra KO mice (n=6) were
immunostained for CD4, CD8, TCR, and CD69. The percentages of CD69-negative (A) and CD69-positive (B) CD8SP TCR
hi (left panels) and CD4SP TCR
hi
thymocytes (right panels) among total TCR
hi cells were compared. By calculation, the cell numbers of CD69
2 CD8SP TCR
hi thymocytes in WT and IL-
15Ra KO mice were about 1.6610
663.8610
5 and 9.0610
562.8610
5, respectively. The cell numbers of CD69
2 CD4SP TCR
hi thymocytes in WT and IL-
15Ra KO mice were about 3.6610
661.3610
5 and 3.2610
661.4610
5, respectively. Data are presented as means 6 SD and were analyzed by single-
classification ANOVA. *p,0.05; n.s., not significant.
doi:10.1371/journal.pone.0033152.g002
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(S1P1), a receptor essential for mature thymocyte emigration.
CD69 downregulation was therefore a regulatory step for
thymocyte development prior to their egress [33–35]. To
determine whether the reduction of peripheral CD8
+ T cells in
IL-15Ra KO mice [20] was a result of a compromised supply
from the thymus, we compared the thymic premigrants defined by
the downregulation of CD69 within SP TCR
hi thymocytes in WT
and IL-15Ra KO mice. IL-15Ra KO mice displayed a significant
reduction in CD69
2 CD8SP TCR
hi thymocytes (Fig. 2A).
However, the CD69
2 CD4SP TCR
hi thymocytes were unaffected.
The frequency of mature CD69
+ CD4SP and CD69
+ CD8SP
Figure 3. Comparison of large SP TCR
hi thymocytes between WT and IL-15Ra KO mice. Total thymocytes were isolated from WT and IL-
15Ra KO mice (n=4) and stained for CD4, CD8, and TCR. (A) Cells were gated into 10 sub-regions (R1 to R10) on the basis of FSC. (B) The frequency of
CD8SP TCR
hi thymocytes in each specified regions is displayed as percentages of total thymocytes (upper panels) or percentages of total SP TCR
hi
thymocytes (lower panels). Data are means 6 SD values. **p,0.005 *p,0.05 Single-classification ANOVA.
doi:10.1371/journal.pone.0033152.g003
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(Fig. 2B). Therefore, the mature CD8SP premigrant subpopula-
tion is selectively impaired in IL-15Ra KO mice.
The selective defect in CD8SP thymocytes was most
prominent in blast cells
It was believed that cycling SP thymocytes started egress
approximately four hours after the initiation of DNA synthesis
[1,8]. We therefore investigated whether premigrant expansion is
also an IL-15 transpresentation-dependent process. Given that cell
expansion is accompanied by blastogenesis [6,8], we first
compared WT SP TCR
hi thymocytes with their IL-15Ra KO
counterparts based on their cell size. Total thymocytes were first
subdivided into ten subpopulations based on their forward scatter
(FSC) by flow cytometry (Fig. 3A). The percentages of CD4SP
TCR
hi or CD8SP TCR
hi cells among the total thymocyte
population and among the TCR
hi thymocyte subpopulations were
further analyzed. The results showed that the percentage of large
CD8SP TCR
hi thymocytes in IL-15Ra KO mice (R5 to R10:
1.1610
663.8610
5, n=4) was significantly reduced as compared
to their WT counterparts (6.2610
665610
5 cells, n=4) (Fig. 3B,
left two panels). In contrast, the percentage of CD4SP cells among
total thymocytes in each gated subpopulation remained compa-
rable between WT (2.1 10
661.9610
6 cells) and IL-15Ra KO
(1.7610
661.5610
5) mice (Fig. 3B, upper right panel). However,
when TCR
hi thymocytes were specifically analyzed, a significant
Figure 4. In vivo proliferation of CD8SP TCR
hi and CD4SP TCR
hi thymocytes analyzed by BrdU incorporation. WT and IL-15Ra KO mice
(n=7) were injected i.p. with BrdU. Total thymocytes were isolated 1 hr later, and the degrees of BrdU incorporation by CD4SP TCR
hi and CD8SP TCR
hi
cells was determined. (A) Upper panel; The BrdU incorporation of IL-15Ra KO CD8SP TCR
hi cells (3.2610
461.1610
3 cells) was compared with that of
WT CD8SP TCR
hi cells (9.4610
463.1610
3 cells). Lower panel; The percentages of WT (1.6610
561.0610
5 cells) and IL-15Ra KO CD4SP TCR
hi
(1.5610
560.7610
5 cells) thymocytes that incorporate BrdU. (B) Values of each experimental group are averaged and the means are indicated by
horizontal lines. Data are presented as means 6 SD. **p,0.005; n.s., not significant. Single-classification ANOVA.
doi:10.1371/journal.pone.0033152.g004
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right panel). As TCR
hi subpopulation is composed exclusively of
CD4SP and CD8SP cells, the inverse change of the percentage
respectively further indicated that IL-15Ra KO CD8SP TCR
hi
thymocytes may be defective in post-selection cell proliferation.
The cells larger than R-10 were excluded from analysis due to the
extremely low percentages of SP thymcoytes (,2%) and significant
variation between mice in this region.
The reduction could be detected by in vivo BrdU
incorporation
To further validate the defect in post-selection cell proliferation
observed in IL-15Ra KO CD8SP TCR
hi thymocytes, WT and IL-
15Ra KO mice were i.p. injected with BrdU. Total thymocytes
were collected one hour later, and the frequency of BrdU
+ cells
within the CD4SP TCR
hi and CD8SP TCR
hi thymocyte
subpopulations was determined by flow cytometry. Whereas the
percentages of CD4SP TCR
hi thymocytes incorporating BrdU
were comparable in WT and IL-15Ra KO mice (Fig. 4A, lower
panel and 4B, upper right panel), IL-15Ra KO CD8SP TCR
hi
thymocytes proliferated to a significantly lesser extent than their
WT counterparts (Fig. 4A upper panel and 4B, upper left panel).
Immature SP thymocytes proliferated equally well in WT and IL-
15Ra KO mice (Fig. 4B lower two panels). These results imply
that the intrathymic expansion of mature CD8SP thymocytes may
be dependent in part on IL-15 transpresentation. In contrast, the
ability of CD4SP thymocytes to proliferate is IL-15-independent.
CD8SP thymocyte expansion is IL-15 transpresentation-
dependent
The binding of IL-15 to its proprietary receptor leads to a
conformational change in the cytokine. This conformational
change in IL-15 enhances its functional activity when bound to
the complex formed by the IL-15Rb and cc chains [36]. Thus,
presentation of IL-15 pre-associated with plate-bound IL-15Ra-Fc
fusion protein has been used in in vitro studies to demonstrate IL-15
transpresentation-dependent proliferation of bcc-bearing NK cells
and peripheral CD8
+ T cells [37–39]. However, neither IL-15 nor
IL-21 alone but the combination of the two cytokines was able to
support in vitro CD8
+ T thymocyte growth [22,26,28]. Therefore,
to investigate the dependence of CD8SP thymcoyte proliferation
on IL-15 transpresentation, total thymocytes isolated from WT
and IL-15Ra KO mice were labeled with CFSE and cultured in
medium containing IL-15, IL-21, or IL-15 and IL-21 in the
presence or absence of plate-bound IL-15Ra-Fc fusion protein.
Five days later, cells were harvested and immunostained for CD4
and CD8, and the intensity of CFSE dilution in each cell subset
were analysed by flow cytometry. As shown in Fig. 5, while WT
CD8SP thymocytes did not exhibit significant proliferation in
medium containing IL-15 or IL-21 alone, cells expanded in
medium containing both cytokines. IL-15Ra KO CD8SP
thymocytes exhibited proliferation only when IL-15 was transpre-
sented by plate-bound IL-15Ra in the presence of IL-21. Neither
WT nor IL-15Ra KO CD4SP thymocytes proliferated in either
condition. These results provide direct evidence that the post-
selection cell proliferation of mature CD8SP thymocytes but not
CD4SP thymocytes was dependent on IL-15 transpresentation.
Reduction in proliferating IL-15Ra KO CD8
+ RTEs
As cycling thymic premigrants stop DNA synthesis upon
engaging in emigration process and subsequently become
peripherally resident RTEs [1], post-selection cell proliferation is
considered a significant contributor to the peripheral T cell pool.
To determine whether RTEs that have recently undergone cell
cycle were also selectively diminished in the periphery of IL-15Ra
KO mice, we examined the frequency of cycling cells among
RTEs from WT and IL-15Ra KO mice. Mice were injected twice
i.p. with BrdU at a 2-hr interval. Four hours after the second BrdU
injection, mice were injected intrathymically with FITC. Cells
from axillary, inguinal, and mesenteric LNs were collected 16 hr
later, immunostained for CD4 and CD8 and analyzed by flow
cytometry. RTEs that had recently undergone cell cycle in the
thymus were identified by incorporation of both FITC and BrdU
(Fig. 6A). Whereas the percentages of FITC-gated BrdU
+ CD4
+
RTEs were similar in WT and IL-15Ra KO mice, FITC
+ BrdU
+
CD8
+ RTEs were significantly reduced in IL-15Ra KO mice
(Fig. 6B). These results suggest that the selectively reduced
proliferation of IL-15Ra KO CD8SP thymocytes was also
reflected in peripheral CD8
+ T cells, potentially contributing to
the diminished peripheral CD8
+ T cell pool in IL-15Ra KO mice.
Discussion
In this study, we have demonstrated for the first time a unique
IL-15-dependent cell expansion at the mature CD8SP stage of
thymocyte development. This phenomenon was observed through
multiple experiments focusing on CD69 downregulation, cell size
Figure 5. In vitro stimulation of CD8SP thymocyte proliferation
with plate-bound IL-15-IL-15Ra-Fc proteins. Total thymocytes
were labeled with CFSE and then cultured in medium supplemented
with IL-15, IL-21, both IL-15 and IL-21, or both IL-15 and IL-21 with pre-
coated rmIL-15Ra-Fc fusion protein. The cultures were supplemented
with the same amounts of cytokine 3 days later. Cells were harvested 5
days after the initiation of the culture and stained for CD4 and CD8. The
extent of cell proliferation in CD8SP thymocytes was analyzed by
measuring CFSE dilution. The data are representative of three
independent experiments.
doi:10.1371/journal.pone.0033152.g005
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with experiments utilizing in vitro culture conditions that mimic IL-
15 transpresentation and experiments tracing the appearance of
thymically FITC-labeled BrdU
+ CD8
+ T cells in the lymph nodes,
these finding provide important physiological insights into the role
of IL-15 in CD8
+ T cell biology.
It has been established that IL-15 is indispensable for the
maintenance of peripheral CD8
+ T cells [19,20,40], which is
achieved through the ability of IL-15 to support naı ¨ve peripheral
CD8
+ T cell survival rather than their homeostatic proliferation
[20,41]. Although this study demonstrated the IL-15-dependent
proliferation of CD8SP thymocytes, previous studies showed that
Figure 6. The dependence of CD8
+ RTEs on IL-15 transpresentation. Mice were injected twice i.p.with BrdU at a 2-hr interval. Four hours after
the second BrdU injection, mice were injected intrathymically with FITC or subjected to a sham operation (n=6). (A) Cells were collected from the LNs
16 hours later and immunostained for the expression of CD8 (left panels) and CD4 (right panels). (B) The frequencies of BrdU
+ FITC
+ CD8
+ or BrdU
+
FITC
+ CD4
+ LN cells among FITC
+ RTEs were compared. **p,0.005; n.s., not significant.
doi:10.1371/journal.pone.0033152.g006
IL-15 Transpresentation Dependent Tymic Expansion
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thymocytes unless the negative regulator SOCS-1 was ablated
[23,25]. This study and others [23,42] have demonstrated that
stimulation with IL-15 and IL-21 induced the expansion of
CD8SP thymocytes, suggesting that a synergistic effect upon
STAT5 phosphorylation by IL-15 and IL-21 may override the
negative effect of SOCS-1 and drive CD8SP thymocyte expansion
[23,43]. IL-21 alone acts through the induction of STAT1 and
STAT3 in peripheral CD8
+ T cells; however, IL-21 is not
sufficient to induce CD8
+ T cell expansion even in the absence of
SOCS-1 [44]. The essential role of STAT5 phosphorylation in the
IL-15-dependent proliferation of CD8SP thymocytes is in contrast
to the lack of significant phosphorylation by IL-15 in CD4SP
thymocytes in either the presence or absence of SOCS-1 [23,27],
underlining the restriction of this phenomenon to the CD8SP
subset. In addition to inhibiting negative regulation or positively
enhancing the STAT5 signals, a study of human CD8SP
thymocytes cultured for 3 weeks suggests that the continuous
addition of IL-15 may also drive CD8SP thymocytes into cell cycle
[45]. However, proliferation of the culture cells was not specifically
measured; the possibility that IL-15 plays a role in supporting cell
survival cannot be excluded.
The extent of peripheral TCR diversity was significantly
contributed by T cell progenitor expansion [4,5] that was
promoted by cytokine receptor signaling [46,47]. Analysis of
gene-ablated mice has shown that the expansion of the earliest
progenitors CD44
+CD25
2 DN thymocytes is dependent on c-kit
[48]. The blockade of T cell development at the following
CD44
+CD25
+,CD44
2CD25
+, and CD44
2CD25
2 DN stages in
cc
2/2 mice indicated that cc cytokine family members are also
crucial for the development of DN thymic progenitors [12,49,50].
Mice deficient in IL-7 or IL-7Ra and double knock out of IL-7Ra
and IL-2, or IL-7Ra and IL-4 demonstrated a similar blockade at
the CD44
+CD25
+ DN stage, suggesting that IL-7, but not other
cc-dependent cytokines play an important role in the development
of DN thymic progenitors [48,51]. This notion was further
supported by the normal T cell development in mice deficient in
IL-2 [52], IL-2Ra [53], IL-4 [54], and IL-15Ra [20] and mice
deficient in both IL-2 and IL-4 [55]. In addition, a body of
evidence has been attributed to the additional diversity of TCR
repertoire and the maintenance of the peripheral T cell pool to the
expansion of mature thymocytes [1,6,56,57]. IL-7 has been shown
essential for the expansion of both CD4SP and CD8SP mature
thymocytes [7,58]. This report demonstrated that CD8SP
thymocytes require an additional IL-15-dependent step to multiply
in number before egress into circulation.
As for the cell types that transpresent IL-15 in the thymus, a
previous study showed that mouse thymic epithelial cells (TECs)
were able to drive mature thymocyte expansion [6]. Semiquan-
titative RT-PCR results also suggest that these cells constitutively
express IL-15 [58,59]. Moreover, TECs have recently been
reported to transpresent IL-15 to support thymic cell development
[60]. It is therefore possible that the unique expansion of mature
CD8SP T cell premigrants is triggered through the IL-15 signal
delivered by thymic stromal cells such as TECs.
Failure to maintain adequate peripheral TCR diversity and
pool size is often evident in the elderly due to ageing-related
thymic involution that is further exacerbated by diseases arising
from chemotherapy, radiotherapy, or viral infection [6]. The
subsequent homeostatic proliferation of the residual TCR
repertoire-restricted peripheral T cells [61,62] leads to the
establishment of large CD8
+ T cell clones [63] that results in a
bias towards autoreactivity and increased incidence of autoimmu-
nity [56,64–68] and a decline in T-cell function [69]. Use of IL-7
has provided a future thymic rejuvenation strategy [67,70,71] for
the treatment of thymic atrophy-associated immune problems and
lymphopenia-related diseases. This study indicates that IL-15
could be an additional candidate to rejuvenate the thymus and
maintain TCR repertoire that warrants further investigation via
the use of aged WT and IL-15Ra KO mice.
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